Novo Nordisk Aktie
40,75EUR | -1,46EUR | -3,46% |
WKN DE: A3EU6F / ISIN: DK0062498333
Diese Analysten bewerten die Novo Nordisk-Aktie
Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
---|---|---|---|---|---|---|
UBS AG | 340,00DKK | 11,15% | 05.08.25 | |||
Goldman Sachs Group Inc. | 400,00DKK | 30,76% | 04.08.25 | |||
Bernstein Research | 620,00DKK | 102,68% | 01.08.25 | |||
Barclays Capital | 375,00DKK | 22,59% | 30.07.25 | |||
JP Morgan Chase & Co. | 500,00DKK | 63,45% | 30.07.25 | |||
Deutsche Bank AG | 750,00DKK | 145,18% | 18.07.25 | |||
Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 610,00DKK | 99,41% | 15.07.25 | |||
Jefferies & Company Inc. | 415,00DKK | 35,67% | 23.06.25 |
Historische Rating-Entwicklung
0
Buy
0
Hold
0
Sell
Aktuell
|
0
Buy
0
Hold
0
Sell
vor 1/2 Jahr
|
0
Buy
0
Hold
0
Sell
vor 1 Jahr
|